Abstract:BACKGROUND:Growing evidence indicates that endometriosis is an epigenetic disease. Encouragingly, histone deacetylases (HDACs) and DNA methyltransferases have been shown to be promising targets by numerous in vitro studies. However, only a few studies have shown promising effects of HDAC inhibition in preclinical studies in endometriosis. While lysine-specific demethylase 1 (LSD1) is recently found to be aberrantly expressed in endometriosis, and that the treatment of endometriotic stromal cells with tranylcypromine (TC), an LSD1 inhibitor, significantly reduced cellular proliferation, cell cycle progression, and invasiveness, the in vivo effect of TC treatment is currently lacking. This study sought to evaluate the effect of TC in a mouse model of endometriosis.METHODS:Forty-seven female C57BL/6 mice were used in this experimentation. All mice, except those randomly selected to form Sham surgery (M) and specificity control (S) groups, received an endometriosis-inducing surgery. Group S was set up mainly to ensure that the reduced generalized hyperalgesia in mice treated with TC is not due to any possible analgesic effect of TC, but rather resulting from the treatment effect specific to endometriosis. Two weeks after the surgery, mice that received surgery were further divided randomly into 3 groups: 1) untreated group (U); 2) low-dose TC group (L); 3) high-dose TC group (H). Group S received the same treatment as in group H. Two weeks after treatment, all mice were sacrificed and their ectopic endometrial tissues were harvested and analyzed by immunohistochemistry analysis. Hotplate test was administrated to all mice before the induction, treatment and sacrifice. Lesion size, hotplate latency, immunoreactivity against markers of proliferation, angiogenesis, H3K4 methylation, and of epithelial-mesenchymal transition (EMT).RESULTS:TC treatment significantly and substantially reduced the lesion size and improved generalized hyperalgesia in a dose-dependent fashion in mice with induced endometriosis. In addition, TC treatment resulted in reduced immunoreactivity to biomarkers of proliferation, angiogenesis, and H3K4 methylation, leading to arrested EMT and lesion growth.CONCLUSION:In light of our previously reported reduced cellular proliferation, cell cycle progression and invasiveness resulting from the LSD1 inhibition in in vitro studies, our data strongly suggest that LSD1 is a promising therapeutic target for endometriosis.TRIAL REGISTRATION:Not applicable.

Inhibition Of Proliferation Of Endometrial Stromal Cells By Trichostatin A, Ru486, Cdb-2914, N-Acetylcysteine, And Ici 182780

A Small-Molecule Triptolide Regulates Survival and Migration of Stromal Cells from Patients with Endometriosis

Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.

[Effects of ICI182780 (faslodex) on Proliferation and Apoptosis Induced by 17Beta-Estradiol in Endometrial Carcinoma Cells].

Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells.

Emerging drugs for endometriosis.

Controlling Semi-Invasive Activity of Human Endometrial Stromal Cells by Inhibiting NF-kB Signaling Pathway Using Aloe-emodin and Aspirin

Effect of A-317491 Delivered by Glycolipid-Like Polymer Micelles on Endometriosis Pain

Trichostatin A, a Histone Deacetylase Inhibitor, Attenuates Invasiveness and Reactivates E-Cadherin Expression in Immortalized Endometriotic Cells

SR‐16234, a Unique Selective Estrogen Receptor Modulator, Suppressed Proliferation and Pain‐Related Factor Expression by Inhibition of the Nuclear Factor‐kappa B Pathway in Endometriotic Stromal Cells

Histone Deacetylase Inhibitors Trichostatin A and Valproic Acid Induce Cell Cycle Arrest and P21 Expression in Immortalized Human Endometrial Stromal Cells.

[Effect of Gonadotropin-Releasing Hormone-I Agonist and Gonadotropin-Releasing Hormone-Ii on Endometrial Carcinoma Cell Lines with Different States of PTEN].

Trichostatin A, A Histone Deacetylase Inhibitor, Reduces Lesion Growth and Hyperalgesia in Experimentally Induced Endometriosis in Mice

Therapeutic Potential of Andrographolide for Treating Endometriosis.

U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-κB Pathway

The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen-receptor-independent manner

[Effects of Parthenolide on Estradiol-Synthesizing Enzyme, ER Isoforms and VEGF in Human Endometriotic Stromal Cells].

Functional Study of Progesterone Receptor Isoforms in Endometrial Cancer Cell Lines

Tranylcypromine, a Lysine-Specific Demethylase 1 (LSD1) Inhibitor, Suppresses Lesion Growth and Improves Generalized Hyperalgesia in Mouse with Induced Endometriosis.

Effects of Ulipristal Acetate on Reactive Oxygen Species and Proinflammatory Cytokine Release by Epithelial and Stromal Cells from Human Endometrium and Endometriosis

Effectiveness of the integration of quercetin, turmeric, and N-acetylcysteine in reducing inflammation and pain associated with endometriosis. In-vitro and in-vivo studies